FIELD: medicine.
SUBSTANCE: dermal flap is simulated in laboratory animals on the second day of experiment. Sildenafil 2.2 mg/kg is introduced intraperitoneally on the first, third and fifth day of the experiment.
EFFECT: dermal flap survival rate in reduced circulation with no side effects.
1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DERMAL FLAP SURVIVAL GROWTH IN REDUCED CIRCULATION WITH MINOXIDIL | 2012 |
|
RU2497201C1 |
METHOD FOR DERMAL FLAP SURVIVAL GROWTH IN REDUCED CIRCULATION WITH L-NORVALINE | 2012 |
|
RU2513619C1 |
METHOD FOR DERMAL FLAP SURVIVAL GROWTH IN REDUCED CIRCULATION WITH RESVERATROL | 2012 |
|
RU2511061C1 |
METHOD FOR PHARMACOLOGICAL STIMULATION OF PEDICLE SKIN FLAP SURVIVAL WITH NICORANDYL | 2012 |
|
RU2507598C1 |
METHOD FOR INCREASING SKIN GRAFT SURVIVAL IN REDUCED CIRCULATION ENVIRONMENT WITH USE OF DIHYDROQUERCETIN | 2014 |
|
RU2547786C1 |
METHOD FOR IMPROVING SURVIVAL RATE OF ISCHEMIC TISSUES (ISOLATED SKIN PEDICLE FLAP) IN REDUCED BLOOD CIRCULATION | 2010 |
|
RU2429547C1 |
METHOD OF PHARMACOLOGICAL CORRECTION OF ISCHEMIC TISSUES SURVIVAL RATE IN REDUCED BLOOD CIRCULATION ENVIRONMENT | 2010 |
|
RU2438190C1 |
METHOD OF PHARMACOLOGICAL CORRECTION OF SCELETAL MUSCLE ISCHEMIA WITH SILNEDAFIL INCLUDING IN L-NAME INDUCED NITROGEN OXIDE DEFICIENCY | 2012 |
|
RU2497203C2 |
METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION IN ADMA-LIKE GESTOSIS MODEL IN EXPERIMENT | 2012 |
|
RU2507594C2 |
METHOD FOR PREVENTION OF ISCHEMIA OF RETINA WITH ERYTHROPOETIN EXPERIMENTALLY | 2013 |
|
RU2539629C1 |
Authors
Dates
2013-11-10—Published
2012-03-30—Filed